NICE Begins Approval Process for New Treatment for Severe Psoriasis
Draft guidelines that back the use of Almirall’s new product Skilarence, for the treatment of moderate or severe plaque psoriasis by the National Health Service in the United Kingdom, have been issued by the National Institute for ...